Enrichment of Astrocyte-Derived Extracellular Vesicles from Human Plasma.


Journal

Journal of visualized experiments : JoVE
ISSN: 1940-087X
Titre abrégé: J Vis Exp
Pays: United States
ID NLM: 101313252

Informations de publication

Date de publication:
03 08 2022
Historique:
entrez: 22 8 2022
pubmed: 23 8 2022
medline: 25 8 2022
Statut: epublish

Résumé

Extracellular vesicles (EVs) are biological nanoparticles secreted by all cells for cellular communication and waste elimination. They participate in a vast range of functions by acting on and transferring their cargos to other cells in physiological and pathological conditions. Given their presence in biofluids, EVs represent an excellent resource for studying disease processes and can be considered a liquid biopsy for biomarker discovery. An attractive aspect of EV analysis is that they can be selected based on markers of their cell of origin, thus reflecting the environment of a specific tissue in their cargo. However, one of the major handicaps related to EV isolation methods is the lack of methodological consensuses and standardized protocols. Astrocytes are glial cells with essential roles in the brain. In neurodegenerative diseases, astrocyte reactivity may lead to altered EV cargo and aberrant cellular communication, facilitating/enhancing disease progression. Thus, analysis of astrocyte EVs may lead to the discovery of biomarkers and potential disease targets. This protocol describes a 2-step method of enrichment of astrocyte-derived EVs (ADEVs) from human plasma. First, EVs are enriched from defibrinated plasma via polymer-based precipitation. This is followed by enrichment of ADEVs through ACSA-1-based immunocapture with magnetic micro-beads, where resuspended EVs are loaded onto a column placed in a magnetic field. Magnetically labeled ACSA-1+ EVs are retained within the column, while other EVs flow through. Once the column is removed from the magnet, ADEVs are eluted and are ready for storage and analysis. To validate the enrichment of astrocyte markers, glial fibrillary acidic protein (GFAP), or other specific astrocytic markers of intracellular origin, can be measured in the eluate and compared with the flow-through. This protocol proposes an easy, time-efficient method to enrich ADEVs from plasma that can be used as a platform to examine astrocyte-relevant markers.

Identifiants

pubmed: 35993755
doi: 10.3791/64107
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Video-Audio Media Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIA NIH HHS
ID : R01 AG056480
Pays : United States
Organisme : NIA NIH HHS
ID : R21 AG056974
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG013566
Pays : United States

Auteurs

Natalia Valle-Tamayo (N)

Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autònoma de Barcelona; Center of Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED).

Rocío Pérez-González (R)

Center of Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED); Movement Disorders Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau.

Gemma Chiva-Blanch (G)

Department of Endocrinology and Nutrition, Hospital Clínic de Barcelona, August Pi i Sunyer Biomedical Research Institute - IDIBAPS; Spanish Biomedical Research Network in Physiopathology of Obesity and Nutrition (CIBEROBN).

Olivia Belbin (O)

Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autònoma de Barcelona; Center of Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED).

Sara Serrano-Requena (S)

Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autònoma de Barcelona; Center of Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED).

Sònia Sirisi (S)

Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autònoma de Barcelona; Center of Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED).

Alba Cervantes González (A)

Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autònoma de Barcelona; Center of Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED).

Oriol Giró (O)

Department of Endocrinology and Nutrition, Hospital Clínic de Barcelona, August Pi i Sunyer Biomedical Research Institute - IDIBAPS; Spanish Biomedical Research Network in Physiopathology of Obesity and Nutrition (CIBEROBN).

Érika Sánchez-Aced (É)

Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autònoma de Barcelona; Center of Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED).

Oriol Dols-Icardo (O)

Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autònoma de Barcelona; Center of Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED).

Daniel Alcolea (D)

Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autònoma de Barcelona; Center of Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED).

María Carmona-Iragui (M)

Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autònoma de Barcelona; Center of Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED).

Amanda Jimenez (A)

Department of Endocrinology and Nutrition, Hospital Clínic de Barcelona, August Pi i Sunyer Biomedical Research Institute - IDIBAPS; Spanish Biomedical Research Network in Physiopathology of Obesity and Nutrition (CIBEROBN).

Alberto Lleó (A)

Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autònoma de Barcelona; Center of Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED).

Juan Fortea (J)

Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autònoma de Barcelona; Center of Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED).

M Florencia Iulita (MF)

Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autònoma de Barcelona; Center of Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED); miulita@santpau.cat.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH